These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 34199494)

  • 1. Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma towards Multi-Target Strategies for Broader Treatment Effects.
    Tezel G
    Cells; 2021 Jun; 10(6):. PubMed ID: 34199494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad perspective on the molecular regulation of retinal ganglion cell degeneration in glaucoma.
    Tezel G
    Prog Brain Res; 2020; 256(1):49-77. PubMed ID: 32958215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.
    Tezel G
    Prog Retin Eye Res; 2022 Mar; 87():100998. PubMed ID: 34348167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma.
    Yang X; Zeng Q; Barış M; Tezel G
    J Neuroinflammation; 2020 Aug; 17(1):252. PubMed ID: 32859212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.
    Al Hussein Al Awamlh S; Wareham LK; Risner ML; Calkins DJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic axonal degeneration pathways are critical for glaucomatous damage.
    Howell GR; Soto I; Libby RT; John SW
    Exp Neurol; 2013 Aug; 246():54-61. PubMed ID: 22285251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
    Vernazza S; Oddone F; Tirendi S; Bassi AM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection.
    Bastola T; Perkins GA; Kim KY; Choi S; Kwon JW; Shen Z; Strack S; Ju WK
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of distinct caspase-8 functions in retinal ganglion cells and astroglia in experimental glaucoma.
    Yang X; Zeng Q; Tezel G
    Neurobiol Dis; 2021 Mar; 150():105258. PubMed ID: 33434617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells.
    Ju WK; Perkins GA; Kim KY; Bastola T; Choi WY; Choi SH
    Prog Retin Eye Res; 2023 Jul; 95():101136. PubMed ID: 36400670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
    Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
    J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of Glaucomatous Neurodegeneration by Differentially Modulating Neuronal Endoplasmic Reticulum Stress Molecules.
    Yang L; Li S; Miao L; Huang H; Liang F; Teng X; Xu L; Wang Q; Xiao W; Ridder WH; Ferguson TA; Chen DF; Kaufman RJ; Hu Y
    J Neurosci; 2016 May; 36(21):5891-903. PubMed ID: 27225776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIBP protects retinal ganglion cells against neuroinflammation and mitochondrial dysfunction in glaucomatous neurodegeneration.
    Choi SH; Kim KY; Perkins GA; Phan S; Edwards G; Xia Y; Kim J; Skowronska-Krawczyk D; Weinreb RN; Ellisman MH; Miller YI; Ju WK
    Redox Biol; 2020 Oct; 37():101703. PubMed ID: 32896719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic and synaptic protection: is it enough to save the retinal ganglion cell body and axon?
    Morquette JB; Di Polo A
    J Neuroophthalmol; 2008 Jun; 28(2):144-54. PubMed ID: 18562848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
    Zhu Y; Zhang L; Gidday JM
    Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.
    Syc-Mazurek SB; Fernandes KA; Wilson MP; Shrager P; Libby RT
    Mol Neurodegener; 2017 Oct; 12(1):71. PubMed ID: 28969695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model.
    Munemasa Y; Kitaoka Y; Kuribayashi J; Ueno S
    J Neurochem; 2010 Dec; 115(6):1508-19. PubMed ID: 20950337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JUN is important for ocular hypertension-induced retinal ganglion cell degeneration.
    Syc-Mazurek SB; Fernandes KA; Libby RT
    Cell Death Dis; 2017 Jul; 8(7):e2945. PubMed ID: 28726785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
    Wareham LK; Dordea AC; Schleifer G; Yao V; Batten A; Fei F; Mertz J; Gregory-Ksander M; Pasquale LR; Buys ES; Sappington RM
    Neurobiol Dis; 2019 Jan; 121():65-75. PubMed ID: 30213732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.